Levine, M N <br/><br/>
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.  [electronic resource] 

 -  Thrombosis and haemostasis  Nov 1989 
 - 940-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Factor Xa Inhibitors<br/>Hematoma--etiology<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Hip Prosthesis--adverse effects<br/>Humans<br/>Postoperative Complications--prevention & control<br/>Thrombophlebitis--prevention & control